设为首页         

资讯内容 Content

ESC重磅丨5大指南、26项最新临床研究闪耀巴黎!
国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

 编辑:国际循环网 时间:2019/7/23 11:37:07    加入收藏
 关键字:ESC重磅 
  2019欧洲心脏病学学会年会(ESC 2019)将于8月31日~9月4日在法国-巴黎盛大召开。今年ESC大会与世界心脏病学大会一起举办,聚焦全球心血管健康,重点关注全球心血管疾病发病率,临床表现,预防策略,诊断方式和管理方面的差异。同时,大会将重磅发布5大临床实践指南和26项最新临床研究,来自150个国家的3.2万名心血管领域专家学者参会,5天的学术日程展示4500篇研究摘要,设置500场专家讨论会,400个心血管领域热点话题。届时,《国际循环》将进行现场同步报道,敬请关注大会更多精彩内容!
 
 
5大临床实践指南
 
  2019 ESC/EASD Guidelines on Diabetes, Pre-diabetes and Cardiovascular Diseases
  2019 ESC/EASD糖尿病、糖尿病前期和心血管疾病指南
 
  2019 ESC Guidelines on Acute Pulmonary Embolism
  2019 ESC急性肺栓塞指南
 
  2019 ESC Guidelines on Supraventricular Tachycardias
  2019 ESC室上性心动过速指南
 
  2019 ESC Guidelines on Chronic Coronary Syndromes
  2019 ESC慢性冠状动脉综合征指南
 
  2019 ESC/EAS Guidelines on Dyslipidaemias
  2019 ESC/EAS血脂异常指南
 
26项最新临床研究
 
  Sun 01 Sep  14:30 - 15:50
  Paris - Main Auditorium
 
  THEMIS - Main Results of the Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study
  THEMIS:替格瑞洛对糖尿病患者干预研究中健康结局影响的主要结果
 
  THEMIS-PCI: Ticagrelor in Patients with Diabetes and Stable Coronary Artery Disease with a History of Prior Percutaneous Coronary Intervention
  THEMIS-PCI:替格瑞洛在既往行PCI治疗的糖尿病和稳定性冠状动脉疾病患者中的应用
 
  PARAGON-HF - Angiotensin Receptor Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
  PARAGON-HF:血管紧张素受体-脑啡肽酶抑制剂在射血分数保留的心力衰竭患者中的应用
 
  COMPLETE Revascularization with Multivessel Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction
  STEMI患者多支血管PCI的完全血运重建
 
  Sun 01 Sep  16:40 - 17:52
  Paris - Main Auditorium
 
  NZOTACS - The New Zealand Oxygen Therapy in Acute Coronary Syndromes trial
  NZOTACS :新西兰氧疗法治疗急性冠状动脉综合征(ACS)
 
  CONDI-2/ERIC-PPCI - Effect of remote ischemic conditioning on clinical outcomes in patients with ST- segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
  CONDI-2/ERIC-PPCI:远端缺血适应对行PCI治疗的STEMI患者临床疗效的影响
 
  ISAR-REACT 5 - Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome
  ISAR-REACT 5:替格瑞洛vs. 普拉格雷治疗ACS
 
  HiSTORIC - High-Sensitivity cardiac Troponin On presentation to Rule out myocardial InfarCtion: A stepped-wedge cluster randomised controlled trialc
  HiSTORIC:高敏肌钙蛋白在心肌梗死治疗中的应用——阶梯楔形群随机对照试验
 
  Mon 02 Sep  11:00 - 12:30
  Paris - Main Auditorium
 
  Combined effect of lower LDL-C and lower SBP on the lifetime risk of cardiovascular disease
  低LDL-C和低SBP对心血管疾病终生风险的综合影响
  AFIRE - Rivaroxaban monotherapy versus combination therapy in patients with atrial fibrillation and stable coronary artery disease
 
  AFIRE:利伐沙班单药治疗和联合治疗在心房颤动和稳定性冠状动脉疾病患者中的比较
  GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial
  GALACTIC:急性充血性心脏失代偿的降后负荷达标治疗随机对照试验
 
  Salt substitution and community-wide reductions in blood pressure and hypertension incidence
  盐替代和社区范围内的血压和高血压发病率降低
 
  HOPE 4 - Impact on cardiovascular risk of a community-based multi-faceted intervention in individuals with hypertension in 2 middle income countries: The Heart Outcomes Prevention and Evaluation 4 study
  HOPE 4 :对2个中等收入国家的高血压患者进行基于社区的多方面干预对心血管风险的影响——心脏预后评估研究4
 
  Mon 02 Sep  16:40 - 17:52
  Paris - Main Auditorium
 
  BB-meta-HF - Beta-blockers are effective in high-risk heart failure patients with reduced ejection fraction and moderately-severe renal dysfunction
  BB-meta-HF:β受体阻滞剂对射血分数减低的中度严重肾功能不全的高危心力衰竭患者有效
 
  SYNTAXES - Ten-Year Survival after Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention: The SYNTAX Extended Survival study
  SYNTAXES:冠状动脉旁路移植术vs. PCI术后十年生存率——SYNTAX扩展生存研究
 
  MITRA-FR - 2 years follow-Up of the MITRA-FR study a randomized controlled trial evaluating the effectiveness of percutaneous mitral valve repair in secondary mitral regurgitation
  随机对照MITRA-FR研究2年随访结果,评估经皮二尖瓣修复在继发性二尖瓣关闭不全患者中的有效性
 
  DANAMI-2 - 16-year follow-up of the Danish Acute Myocardial Infarction 2 trial - Primary percutaneous coronary intervention versus fibrinolysis in ST-elevation myocardial infarction
  DANAMI-2:丹麦急性心肌梗死2试验16年随访——STEMI的急诊PCI治疗vs. 纤维蛋白溶解
 
  Tue 03 Sep  11:00 - 12:40
  Paris - Main Auditorium
 
  CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommended therapies. Final 5-year results from the CLARIFY study
  在稳定性冠状动脉疾病中,尽管坚持使用指南推荐的治疗方法,但心绞痛和既往心肌梗死患者的预后较差——CLARIFY研究的最终5年结果
 
  SWEDEHEART - Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry
  冠状动脉旁路移植术后的二级预防药物和长期死亡率:来自SWEDEHEART登记处的纵向人群研究
 
  ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study.
  植入式心律转复除颤器用于心力衰竭一级预防和死亡的相关性:一项前瞻性倾向评分匹配研究
 
  FRANCE-TAVI - Balloon-expandable versus Self-expandable TAVR On ParaValvular Regurgitation And 2-year Mortality: a propensity-matched comparison from the France-TAVI Registry
  FRANCE-TAVI:气囊扩张vs. 自膨胀TAVR对瓣叶返流和2年死亡率的影响
 
  PURE - Contrasting patterns of cardiovascular disease, cancers and related mortality between high- versus low-middle income countries in 21 countries
  PURE:21个国家中的高收入和中低收入国家心血管疾病,癌症和相关死亡率对比
 
  Tue 03 Sep 16:40 - 17:52
  Paris - Main Auditorium
 
  RAPID-TnT - A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T
  一项关于疑似ACS的1小时心肌肌钙蛋白T的随机试验:高敏感肌钙蛋白T在急诊科中快速评估可能的ACS
 
  ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients.
  ENTRUST-AF PCI:房颤患者成功进行冠状动脉支架置入后,依度沙班和维生素K拮抗剂的抗栓方案对比
 
  POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with ST-segment elevation myocardial infarction undergoing primary PCI: a randomized, open-label, multicenter trial
  POPular Genetics:急诊PCI治疗STEMI患者的基因型指导口服P2Y12抑制剂研究
 
  DAPA - Long-term outcome of the Defibrillator After Primary Angioplasty Trial - Implantable Defibrillator Early After Primary Percutaneous Intervention for ST-Elevation Myocardial infarction
  DAPA:急诊血管成形术后除颤器的长期结果——STEMI急诊PCI治疗后早期植入式除颤器
 

相关文章

相关幻灯

相关视频

 
京ICP备15014970号-5   国际循环 版权所有  2008-2022 icirculation.com  All Rights Reserved